BioLargo, Inc.
BLGO
$0.13
-$0.01-5.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -310.26% | -390.42% | -364.86% | -40.22% | 14.18% |
| Total Depreciation and Amortization | 44.48% | 59.22% | 21.74% | 5.99% | 2.75% |
| Total Amortization of Deferred Charges | 721.43% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,157.42% | 709.81% | 240.74% | -103.41% | -91.36% |
| Change in Net Operating Assets | 77.77% | 35.11% | -412.05% | -3,604.50% | -1,005.43% |
| Cash from Operations | -70.09% | -158.80% | -567.41% | -1,373.23% | -199.67% |
| Capital Expenditure | 79.03% | 96.28% | 99.43% | 99.11% | 71.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 686.59% | 686.59% | -- | -- | -- |
| Cash from Investing | 188.77% | 133.03% | 127.81% | 106.11% | 64.89% |
| Total Debt Issued | 112.52% | 48.73% | 3,246.15% | 3,246.15% | 2,136.92% |
| Total Debt Repaid | 69.23% | 100.00% | -146.51% | -142.86% | -139.39% |
| Issuance of Common Stock | 89.59% | 33.53% | 31.67% | 33.07% | 1.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 200.00% | -- | -100.00% | -100.00% | -101.08% |
| Cash from Financing | 149.82% | 85.24% | 145.66% | 80.75% | -0.26% |
| Foreign Exchange rate Adjustments | 72.73% | -125.53% | 150.72% | 148.75% | 15.38% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 187.92% | 3,622.22% | -20.95% | -208.74% | -265.30% |